---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-021863"
form_type: "8-K"
ticker: "AIM"
cik: "0000946644"
company_name: "AIM ImmunoTech Inc."
filed_at: "2026-05-08T23:59:59+00:00"
generated_at: "2026-05-14T21:18:55.537273+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# AIM ImmunoTech expects ~$4.2M gross from warrant inducement at $0.48/share; new warrants at $0.60

## Summary
- Existing warrants from May 2024, Sep 2024, Jul 2025 exercised at reduced exercise price of $0.48; gross proceeds ~$4.2M if fully exercised.
- New Class H inducement warrants at 200% coverage; exercise price $0.60, 5-year term, subject to stockholder approval.
- Placement agent: Ladenburg Thalmann; 8% cash fee, 6% warrant coverage, plus 0.75% management fee.
- Proceeds to be used for working capital and general corporate purposes.
- Company to call stockholder meeting within 75 days post-closing to approve issuance of Inducement Warrant Shares.

## SEC filing metadata
- accession: 0001493152-26-021863
- form_type: 8-K
- ticker: AIM
- cik: 0000946644
- company_name: AIM ImmunoTech Inc.
- filed_at: 2026-05-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/946644/000149315226021863/0001493152-26-021863-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/946644/000149315226021863/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-021863
- JSON: https://secwatch.observer/filing/0001493152-26-021863.json
- Plain text: https://secwatch.observer/filing/0001493152-26-021863.txt

## Source-grounded claims
- claim_id: 10aa20efb1a6e695f5e454c485b505e9c01b4971
  claim: AIM ImmunoTech Inc. entered into Inducement Letter with holders of Existing May 2024 Warrants, Existing September 2024 Warrants, and Existing July 2025 Warrants valued at approximately $4.20 million (effective 2026-05-07).
  evidence_excerpt: On May 7, 2026, AIM ImmunoTech Inc. (the “Company”) entered into a warrant exercise inducement offer letter agreement (the “Inducement Letter”) with holders (the “Holders”) of (i) Class A and Class B common stock purchase warrants issued on May 31, 2024
  evidence_url: https://www.sec.gov/Archives/edgar/data/946644/000149315226021863/0001493152-26-021863-index.htm
- claim_id: a912387d6aae7f1b76accf746485fdf49eb38604
  claim: AIM ImmunoTech Inc. entered into Engagement Agreement with Ladenburg Thalmann & Co. Inc. (effective 2026-05-07).
  evidence_excerpt: The Company entered into an engagement agreement (the “Engagement Agreement”) with Ladenburg Thalmann & Co. Inc. (the “Placement Agent”) to act as its placement agent in connection with the transactions summarized above.
  evidence_url: https://www.sec.gov/Archives/edgar/data/946644/000149315226021863/0001493152-26-021863-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.